On Nov. 14, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:
On Nov. 13, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:
On Nov. 10, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Nov. 7, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Nov. 6, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Nov. 4, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Oct. 31 - Nov. 3, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
NEWPORT, R.I. -- Restructuring at the FDA is causing confusion in the agency's approach to import enforcement, according to Domenic Veneziano, a former director of import operations at the agency.
On Oct. 28, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:
On Oct. 27, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of: